Delivery Order SPE2DB25D3020-SPE2DB25FWHSS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of INGREZZA 40 mg capsules (30-count packages) with a ceiling value of $7,352.24. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 6, 2025. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for INGREZZA 80 mg capsules (30-count) on September 15, 2025, with completion targeted for October 6, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of involuntary movement disorders,...
- The Defense Logistics Agency awarded a $7,352.24 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of INGREZZA 40 mg capsules (30-count units). This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) with a contract ceiling value of $11,028.36. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) with a ceiling value of $7,352.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation and reflects the agency's procurement of...
- On July 29, 2025, the Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 19, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 MG capsules (30-count packaging) with an ultimate completion date of August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp, a major pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a $4,027.70 delivery order (Contract No. 4568785833) by the Defense Logistics Agency on July 14, 2025, for the supply of INGREZZA 80 mg capsules (30-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of tardive dyskinesia, a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 MG capsules (30-count units) under a firm fixed price contract. The award, issued on August 25, 2025, with a completion date of September 16, 2025, represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWHSSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,049.61 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of INGREZZA 60 mg capsules (30-count units). This is a firm fixed price delivery order with no set-aside designation, issued competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies a completion date of June 17, 2025, and identifies AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company holds a comprehensive IDC valued at $999,999,999.00 with DLA Troop Support Medical running through December 2026, which enables the delivery of a broad range of pharmaceutical products and medical supplies globally. This INGREZZA order reflects the company's ongoing role in supplying specialty medications across multiple therapeutic domains to support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 5/27/25 |